Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Next-generation T-cells-plattform for precision immunomonitoring of autoimmune diseases

Reference number
Coordinator NEOGAP Therapeutics AB
Funding from Vinnova SEK 200 000
Project duration October 2025 - April 2026
Status Ongoing
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: Competence Enhancement in Small Businesses 2025

Important results from the project

Our goal was to receive competence strenghtening for a limited period from an external consultant to conduct a market investigation, identify stakeholders and collaboration partners, develop product and marketing materials, and develop an evidence generation plan. Outcome: The goal of the project was met earlier than expected and gave us new, important knowledge. Support and competence enhancement has been received from an external consultant with solid experience in the field.

Expected long term effects

As a results of the project, new projects are expected to be started to take the product to market: 1) A production project aiming to ensure quality and documentation of the production process, and 2) New collaboration projects as well as beta test studies to validate the product prior to launch.

Approach and implementation

We have worked according to plan. The work was carried out in the form of sub-activities with frequent and regular coordination meetings. The collaboration and transfer of knowledge has worked very well and smoothly.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 3 March 2026

Reference number 2025-02928